Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 Global Vaccine Market Overview
8.1 Key Industry Highlights
8.2 Global Vaccine Historical Market (2019-2025)
8.3 Global Vaccine Market Forecast (2026-2035)
9 Latin America Vaccine Market Analysis
9.1 Key Industry Highlights
9.2 Latin America Vaccine Historical Market (2019-2025)
9.3 Latin America Vaccine Market Forecast (2026-2035)
10 Latin America Vaccine Market by Technology
10.1 Recombinant and Conjugate Vaccine
10.1.1 Market Share
10.1.2 Historical Trend (2019-2025)
10.1.3 Forecast Trend (2026-2035)
10.2 Inactivated Vaccines
10.2.1 Market Share
10.2.2 Historical Trend (2019-2025)
10.2.3 Forecast Trend (2026-2035)
10.3 Live Attenuated Vaccines
10.3.1 Market Share
10.3.2 Historical Trend (2019-2025)
10.3.3 Forecast Trend (2026-2035)
10.4 Toxoid Vaccines
10.4.1 Market Share
10.4.2 Historical Trend (2019-2025)
10.4.3 Forecast Trend (2026-2035)
10.5 Others
11 Latin America Vaccine Market by Indication
11.1 Pneumococcal Disease
11.1.1 Market Share
11.1.2 Historical Trend (2019-2025)
11.1.3 Forecast Trend (2026-2035)
11.2 Influenza
11.2.1 Market Share
11.2.2 Historical Trend (2019-2025)
11.2.3 Forecast Trend (2026-2035)
11.3 Human Papilloma Virus
11.3.1 Market Share
11.3.2 Historical Trend (2019-2025)
11.3.3 Forecast Trend (2026-2035)
11.4 Meningococcal Disease
11.4.1 Market Share
11.4.2 Historical Trend (2019-2025)
11.4.3 Forecast Trend (2026-2035)
11.5 Rotavirus
11.5.1 Market Share
11.5.2 Historical Trend (2019-2025)
11.5.3 Forecast Trend (2026-2035)
11.6 Varicella, Measles, Mumps, and Rubella
11.6.1 Market Share
11.6.2 Historical Trend (2019-2025)
11.6.3 Forecast Trend (2026-2035)
11.7 Diphtheria, Pertussis, and Tetanus (DPT)
11.7.1 Market Share
11.7.2 Historical Trend (2019-2025)
11.7.3 Forecast Trend (2026-2035)
11.8 Polio
11.8.1 Market Share
11.8.2 Historical Trend (2019-2025)
11.8.3 Forecast Trend (2026-2035)
11.9 Hepatitis
11.9.1 Market Share
11.9.2 Historical Trend (2019-2025)
11.9.3 Forecast Trend (2026-2035)
11.10 JE (Japanese Encephalitis) Vaccine
11.10.1 Market Share
11.10.2 Historical Trend (2019-2025)
11.10.3 Forecast Trend (2026-2035)
11.11 Others
12 Latin America Vaccine Market by End User
12.1 Paediatric Vaccine
12.1.1 Market Share
12.1.2 Historical Trend (2019-2025)
12.1.3 Forecast Trend (2026-2035)
12.2 Adult Vaccine
12.2.1 Market Share
12.2.2 Historical Trend (2019-2025)
12.2.3 Forecast Trend (2026-2035)
12.3 Travellers Vaccine
12.3.1 Market Share
12.3.2 Historical Trend (2019-2025)
12.3.3 Forecast Trend (2026-2035)
13 Latin America Vaccine Market by Country
13.1 Brazil
13.1.1 Market Share
13.1.2 Historical Trend (2019-2025)
13.1.3 Forecast Trend (2026-2035)
13.2 Argentina
13.2.1 Market Share
13.2.2 Historical Trend (2019-2025)
13.2.3 Forecast Trend (2026-2035)
13.3 Mexico
13.3.1 Market Share
13.3.2 Historical Trend (2019-2025)
13.3.3 Forecast Trend (2026-2035)
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 GlaxoSmithKline plc
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Novartis AG
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Pfizer Laboratories Ltd
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Sanofi
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 AstraZeneca plc.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Latin America Vaccine Market: Key Industry Highlights, 2019 and 2035
2. Latin America Vaccine Historical Market: Breakup by Technology (USD Million), 2019-2025
3. Latin America Vaccine Market Forecast: Breakup by Technology (USD Million), 2026-2035
4. Latin America Vaccine Historical Market: Breakup by Indication (USD Million), 2019-2025
5. Latin America Vaccine Market Forecast: Breakup by Indication (USD Million), 2026-2035
6. Latin America Vaccine Historical Market: Breakup by End User (USD Million), 2019-2025
7. Latin America Vaccine Market Forecast: Breakup by End User (USD Million), 2026-2035
8. Latin America Vaccine Historical Market: Breakup by Country (USD Million), 2019-2025
9. Latin America Vaccine Market Forecast: Breakup by Country (USD Million), 2026-2035
10. Latin America Vaccine Market Structure